WUHAN, CHINA, October 26, 2020--MGI’s ground-breaking ceremony of “Intelligent Manufacturing and R&D Base” was officially launched in Guanggu Wuhan. The R&D Base is located at Shendun Road 2, East Lake New Technology Development Zone, Wuhan, with an infrastructure investment of 1.264 billion yuan and a total investment of 2.4 billion yuan. The project is expected to complete the first phase in 2022 with a total construction area of 86,000 square meters. The ground-breaking ceremony o...

On the morning of September 29, 2020, four vehicle-mounted nucleic acid testing labs, co-developed by BGI_MGI and Shudu Bus, are ready to launch in Sichuan. They are equipped with MGI’s automation equipment and intelligent laboratory management system, and it only takes four persons to achieve a daily throughput of up to 20,000, making them one of the most efficient and mobile package on the market. With a tight schedule and heavy workload, the project carries the important mission of ...

CHENGDU, CHINA, September 29, 2020 – four vehicle-mounted nucleic acid testing labs, co-developed by BGI_MGI and Shudu Bus, are ready to launch in Sichun. They are equipped with MGI’s automation equipment and intelligent laboratory management system, and it only takes four persons to achieve a daily throughput of up to 20,000, making them one of the currently most efficient and movable packages on the market. The Mobile PCR Lab will be officially launched and delivered to key medical and...

BGI & MGI provide founding member Task Force Lab (TFL) immediate access to US FDA EUA COVID-19 testing equipment and reagents to ramp up capacity and reduce turnaround times San Jose, Calif. – September 22, 2020 – Today, BGI and MGI announced a “In addition to delivering a world-class technology solution for COVID-19 testing programs like TFL’s, we are pleased to assure our partners that they have access to near limitless testing supplies, both extraction and detection, at a crucial...

Recently, China’s National Medical Products Administration officially released the “Standards for High-throughput Sequencers” (No. YY/T 1723-2020), which is the first national standard for gene sequencing in the medical device industry and the first international standard for gene sequencers, demonstrating China's forward-looking and advancement in the field of gene sequencing. The standard was initiated by National Institutes for Food and Drug Control (Center for Medical Device Standa...

MGI is partnering with SIMED Peru to provide COVID-19 testing packages for UNILABS and INS (Peru’s National Institute of Health) to meet demand for timely testing and reliable results at scale. Since the first case of COVID-19 was confirmed in March, the disease has spread in the country rapidly. On March 22, Peruvian President Martín Vizcarra set a daily testing capacity goal of 5,000. A molecular preventive laboratory was proposed, but the country’s Ministry of Health has now priori...